Champions Oncology, Inc. (CSBR)

Market Cap	81.03M -9.5%
Revenue (ttm)	57.95M -1.1%
Net Income	-2.34M
EPS	-0.17
Shares Out	13.89M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,342
Open	5.92
Previous Close	5.85
Day's Range	5.84 - 5.92
52-Week Range	5.50 - 9.63
Beta	0.43
Analysts	Strong Buy
Price Target	12.00 (+105.66%)
Earnings Date	Mar 12, 2026

About CSBR

Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers...

• Industry: Biotechnology
• Sector: Healthcare
• IPO Date: Mar 25, 1986
• Employees: 213
• Stock Exchange: NASDAQ
• Ticker Symbol: CSBR
• Website: https://www.championsoncology.com

Analyst Summary

According to one analyst, the rating for CSBR stock is "Strong Buy" and the 12-month stock price target is $12.0.

Price Target

$12.0

(105.66% upside)

Analyst Consensus: Strong Buy